Point72 Europe (London) LLP Mckesson Corp Transaction History

Point72 Europe (London) LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$518.81 - $607.81 $950,978 - $1.11 Million	-1,833 Reduced 7.33%	23,190 $13.5 Million
Q1 2024 May 15, 2024	BUY	$473.42 - $539.26 $2.04 Million - $2.32 Million	4,300 Added 20.75%	25,023 $13.4 Million
Q4 2023 Feb 14, 2024	SELL	$437.42 - $470.64 $2.23 Million - $2.4 Million	-5,102 Reduced 19.76%	20,723 $9.59 Million
Q3 2023 Nov 14, 2023	BUY	$402.4 - $446.42 $4.42 Million - $4.9 Million	10,975 Added 73.91%	25,825 $11.2 Million
Q2 2023 Aug 14, 2023	BUY	$354.01 - $427.31 $5.26 Million - $6.35 Million	14,850 New	14,850 $6.35 Million

1,690

109M

1.66M

968K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $90.3B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Point72 Europe (London) LLP, based on Form 13F filings with the SEC.

Stay updated on Point72 Europe (London) LLP with notifications on news.